Please use this identifier to cite or link to this item: https://repositorio.usj.es/handle/123456789/789

Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuñoz, Maria-
dc.contributor.authorDommerholt, Jan-
dc.contributor.authorPérez-Palomares, Sara-
dc.contributor.authorHerrero Gállego, Pablo-
dc.contributor.authorCalvo Carrión, Sandra-
dc.date.accessioned2022-06-08T11:06:04Z-
dc.date.available2022-06-08T11:06:04Z-
dc.date.issued2022-01-07-
dc.identifier.citationMuñoz M, Dommerholt J, Pérez-Palomares S, Herrero P, Calvo S. Dry Needling and Antithrombotic Drugs. Volume 2022, ISSN 12036765, https://doi.org/10.1155/2022/1363477es_ES
dc.identifier.issn1203-6765es_ES
dc.identifier.urihttps://repositorio.usj.es/handle/123456789/789-
dc.description.abstractMany clinicians increasingly use dry needling in clinical practice. However, whether patients’ intake of antithrombotic drugs should be considered as a contraindication for dry needling has not been investigated to date. As far as we know, there are no publications in analyzing the intake of antiplatelet or anticoagulant agents in the context of dry needling techniques. A thorough analysis of existing medications and how they may impact various needling approaches may contribute to improved evidenceinformed clinical practice. +e primary purpose of this paper is to review the current knowledge of antithrombotic therapy in the context of dry needling. In addition, reviewing guidelines of other needling approaches, such as electromyography, acupuncture, botulinum toxin infiltration, and neck ultrasound-guided fine-needle aspiration biopsy, may provide specific insights relevant for dry needling. Based on published data, taking antithrombotic medication should not be considered an absolute contraindication for dry needling techniques. As long as specific dry needling and individual risks are properly considered, it does not change the risk and safety profile of dry needling. Under specific circumstances, the use of ultrasound guidance is recommended when available.es_ES
dc.format.extent10 p.es_ES
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherHindawi Limitedes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectBotulinum toxin injectionses_ES
dc.subjectRegular physical-activityes_ES
dc.subjectOral anticoagulantses_ES
dc.subjectAdverse eventses_ES
dc.subjectAtrial-fibrillationes_ES
dc.subjectBleeding complicationses_ES
dc.subjectAntiplatelet therapyes_ES
dc.subjectHematoma riskes_ES
dc.subjectWarfarines_ES
dc.subjectAcupunturees_ES
dc.titleDry Needling and Antithrombotic Drugses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doihttps://doi.org/10.1155/2022/1363477es_ES
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesses_ES
Appears in Collections:Artículos de revistas

Files in This Item:
File Description SizeFormat 
Dry Needling and Antithrombotic Drugs.pdf1,29 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons